InvestorsHub Logo
Followers 121
Posts 2016
Boards Moderated 0
Alias Born 11/20/2012

Re: None

Tuesday, 01/01/2013 12:21:30 PM

Tuesday, January 01, 2013 12:21:30 PM

Post# of 130512
Good Enough for Gilead Sciences Good Enough for AMBS:

On December 12, 2012, Foster City, California-based biopharmaceutical company Gilead Sciences and Canadian drug development company YM BioSciences announced that they have signed a definitive agreement under which Gilead will acquire YM for US$2.95 per share in cash, or approximately US$510 million. Wilson Sonsini Goodrich & Rosati advised Gilead in connection with the transaction.

The legal team is the real deal and now opened an office in Bejing, the Chinese Connection